SynBiotic SE

As of December 31, 2022, SynBiotic SE carries a market capitalization of 48.30M, placing it among publicly traded companies globally. Its enterprise value stands at 49.91M, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.

As of December 31, 2022, SynBiotic SE has 4.59M shares outstanding.

These figures are as of December 31, 2022.

As of December 31, 2022, SynBiotic SE maintains a current ratio of 1.40, meaning it holds 1.4x the short-term assets needed to cover near-term liabilities.

As of the close on October 22, 2026, SynBiotic SE's stock has declined approximately 94.58% over the past 52 weeks. The 50-day moving average sits at 0.78, while the 200-day moving average is 1.55.

As of December 31, 2022, SynBiotic SE holds 3.03M in cash and equivalents against 4.45M in total debt, resulting in a net debt position of 2.77M. Total book value stands at 22.59M, with working capital of 2.31M providing operational flexibility.

SynBiotic SE's most recent stock split took place on August 25, 2023.